Frequency Therapeutics Inc (KRRO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $12.10
• Market Cap: $114.33M
• EPS: $-9.42
• 52-Week High: $55.89
• 52-Week Low: $5.20

Market Sentiment

Frequency Therapeutics Inc currently has a Bullish sentiment score of 0.25.

About Frequency Therapeutics Inc

Korro Bio, Inc. is a forward-looking biopharmaceutical company based in Cambridge, Massachusetts, specializing in RNA editing technologies to develop genetic medicines aimed at treating both rare and common diseases. By harnessing innovative science, the company is advancing a diverse pipeline of transformative therapies that seek to address significant unmet medical needs and reshape treatment paradigms across various therapeutic domains. With its strong commitment to delivering breakthrough...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Frequency Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KRRO pay dividends?

Frequency Therapeutics Inc (KRRO) does not currently pay a regular dividend.

What is KRRO's market cap?

Frequency Therapeutics Inc (KRRO) has a market capitalization of $114.33M with a current stock price of $12.10.